If you liked this article you might like

Elliott 'Strategic Initiative' Effort at NRG Could Lead to Asset Sales, Buyout
Why Bristol-Myers Squibb May Be a Merger Target Soon
SEC Punts Chicago Exchange Review to Trump Regulators